In this episode of IDEA Collider, we are joined by Alex Telford, a biotech founder, writer, and thinker based in the San Francisco Bay Area. As the co-founder of Convoke Bio, Alex discusses his journey from studying biochemistry at UCL to founding a company that develops software tools for streamlining biopharmaceutical workflows.
The conversation dives into the impact of AI and language models on the biotech industry, addressing inefficiencies in drug development, and exploring the potential of synthetic biology and personalized medicine. The discussion also touches on the future of drug discovery, China's role in biotech, and the challenges of understanding neuroscience and consciousness. Don't miss this insightful discussion on the future of biopharma innovation!
00:00 Welcome to Idea Collider
00:04 Introducing Alex Telford
01:59 Alex's Journey from UCL to Convoke Bio
05:29 The Mission and Work of Convoke Bio
07:57 Challenges in Pharma Decision Making
14:05 The Role of AI in Pharma
18:26 Knowledge Management and AI
27:58 Staying Updated in the Fast-Moving AI Field
30:25 AI's Impact on Industry Economics
31:38 AI in Clinical Trials and Drug Development
35:56 China's Role in Drug Discovery
39:24 Neuroscience and AI: Blurring the Lines
46:05 Future Predictions in Pharma
51:20 Addressing Cognitive Bias in Pharma
53:13 Concluding Thoughts and Future Directions
Keep up with Alex Telford;
LinkedIn: https://www.linkedin.com/in/alexander-telford/
Website: atelfo.github.io
X: https://twitter.com/atelfo
Substack: atelfo.substack.com
Follow Mike Rea On;
Website: https://www.ideapharma.com/
X: https://x.com/ideapharma
LinkedIn: https://www.linkedin.com/in/bigidea/
Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/
